Obstetrics and gynecology

surgical specialties

The week's innovation in obstetrics and gynecology, published every Sunday for the week before: new technology, AI tools, devices, FDA decisions on new technology and new ways of delivering care, every item linked to its sources.

Early-pregnancy doxycycline tied to higher pregnancy loss risk; mobile coaching fails to cut postpartum BMI; most fibroid patients avoid retreatment

A handheld fetal Doppler joined by a coiled cord to a flat round probe, with soft curved sound arcs rising from the probe.

First-trimester doxycycline was associated with higher risk for pregnancy loss than amoxicillin in a claims cohort of 218,234 pregnant patients with respiratory infections, Annals of Internal Medicine reported Nov. 10. A mobile health coaching trial did not lower postpartum BMI in women at risk of gestational diabetes, and most women stayed free of further fibroid procedures for five to 10 years after uterine-sparing treatment.

  • Research Nov 10, 2026
    A retrospective active-comparator cohort study in Annals of Internal Medicine used MarketScan commercial and Medicaid claims to compare first-trimester doxycycline with other antibiotics in pregnancies with a respiratory tract infection or acne. For respiratory infections, doxycycline was associated with higher risk for pregnancy loss than amoxicillin (adjusted relative risk 1.54, 95% CI 1.41 to 1.68, in MarketScan and 1.40, 95% CI 1.28 to 1.53, in Medicaid), with similar results versus macrolides. For acne, the topical clindamycin comparison was significant in MarketScan (adjusted relative risk 1.49, 95% CI 1.26 to 1.76) but not in Medicaid (1.03, 95% CI 0.80 to 1.33).
  • Technology Nov 12, 2026
    In a multicenter randomized trial in Australia, Ireland, Spain and the U.K., published in The Lancet Digital Health, 865 pregnant women at risk of gestational diabetes, enrolled at 12 to 24 weeks of gestation, were assigned to personalized mobile health coaching through 12 months postpartum or to usual care. Mean BMI change, the primary end point, did not differ between groups (-0.04 kg/m2 with the intervention versus 0.04 kg/m2 with control). Adverse events were recorded in 18% of the intervention group and 25% of controls.
  • Research Nov 10, 2026
    An Obstetrics & Gynecology study recontacted 817 participants from two studies of uterine-sparing leiomyoma procedures, who reported any later procedures, with follow-up of 4.0 to 10.5 years. Within five years of the baseline procedure, 79.1% (95% CI 76.2 to 82.1) had no additional uterine procedure, and 64.1% (95% CI 57.7 to 71.2) had none within 10 years. Compared with myomectomy, radiofrequency ablation was associated with a higher retreatment rate (hazard ratio 1.61, 95% CI 1.08 to 2.40).

Latest news

Tagged obstetrics and gynecology, from the daily briefing

  1. Hyoscine butylbromide plus bicarbonate in labor: 57% vs 56% spontaneous vaginal birth in 3,094 women
  2. Aetna rolls out a program for pregnant women, new mothers and infants
  3. CDC counts 112 measles cases in pregnancy and 13 cases of congenital measles since January 2025

See all the latest news

Earlier weeks

The weekly podcast

Each Sunday's obstetrics and gynecology innovation roundup as a short audio briefing, read by AI voices. Play any episode here, or follow the show in any podcast app.

In any podcast app, add the feed: https://feeds.transistor.fm/physician-in-the-loop-obstetrics-and-gynecology